Tübingen, 72074
Germany
University of Tübingen
nomogram, melanoma, survival, checkpoint inhibitors, anti-PD-1, first line, stage IV
Melanoma, Multicentre, paediatric oncology, pregnancy, Retrospective, Transplacental Metastases
early stage melanoma, CP-GEP, biomarkers, adjuvant therapy, risk stratification
Melanoma, sex, Targeted therapy, immune checkpoint inhibition therapy, Survival